These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16377303)

  • 1. Drawbacks of nonrandomized trials in acute coronary syndromes.
    Biondi-Zoccai GG; Abbate A; Agostoni P; Valgimigli M; Sangiorgi GM
    Am J Cardiol; 2006 Jan; 97(1):151. PubMed ID: 16377303
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction to "Optimizing management of non-ST-segment elevation acute coronary syndromes". Harmonizing advances in mechanical and pharmacologic intervention.
    Boden WE; Pepine CJ
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):1S-6S. PubMed ID: 12644334
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute coronary syndromes without ST-elevation -- treatment].
    Weber M; Hamm C
    Dtsch Med Wochenschr; 2003 Feb; 128(6):273-6. PubMed ID: 12571797
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing unstable angina in high-risk patients.
    Chew DP; Moliterno DJ
    J Invasive Cardiol; 2002 Feb; 14 Suppl A():31A-48A. PubMed ID: 11847404
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction.
    Cannon CP
    Coron Artery Dis; 1999 Dec; 10(8):561-6. PubMed ID: 10599534
    [No Abstract]   [Full Text] [Related]  

  • 6. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.
    American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
    Catheter Cardiovasc Interv; 2000 Dec; 51(4):505-21. PubMed ID: 11108692
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute coronary syndromes.
    McClelland AJ; Owens CG; Walsh S; Adgey AA
    Clin Med (Lond); 2004; 4(1):27-31. PubMed ID: 14998263
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiplatelet therapy for ischemic heart disease.
    Lange RA; Hillis LD
    N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308
    [No Abstract]   [Full Text] [Related]  

  • 9. Routine vs selective invasive strategies in acute coronary syndromes.
    Bavry AA; Kumbhani DJ
    JAMA; 2005 Dec; 294(22):2844-5; author reply 2845-6. PubMed ID: 16352787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment strategy of unstable angina and non-ST-segment elevation myocardial infarction].
    Zaliūnas R
    Medicina (Kaunas); 2002; 38 Suppl 2():11-4. PubMed ID: 12560610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Naina HV; Harris S; Singla A
    JAMA; 2007 Jul; 298(1):37; author reply 37-8. PubMed ID: 17609485
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological treatment of acute coronary syndromes.
    Hughes K
    Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The year in non-ST-segment elevation acute coronary syndromes.
    Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2005 Sep; 46(5):906-19. PubMed ID: 16139143
    [No Abstract]   [Full Text] [Related]  

  • 15. Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes.
    Collet JP; Montalescot G; Golmard JL; Tanguy ML; Ankri A; Choussat R; Beygui F; Drobinski G; Vignolles N; Thomas D
    Am Heart J; 2004 Apr; 147(4):655-61. PubMed ID: 15077081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. For how long should treatment with clopidogrel be continued after coronary stent implantation?
    Rozenman Y
    J Am Coll Cardiol; 2004 Apr; 43(7):1331; author reply 1331-2. PubMed ID: 15063450
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acute coronary syndromes.
    Garcia-Pavia P; Aguiar-Souto P; Silva-Melchor L
    N Engl J Med; 2005 Dec; 353(25):2714-8; author reply 2714-8; discussion 2714-8. PubMed ID: 16379084
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S; Gopal AK; Bahl VK
    Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
    [No Abstract]   [Full Text] [Related]  

  • 20. Contemporary view of the acute coronary syndromes.
    Moustapha A; Anderson HV
    J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.